Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

K92 Mining Inc T.KNT

Alternate Symbol(s):  KNTNF

K92 Mining Inc. is a Canada-based company, which is engaged in the production of gold, copper and silver at the Kainantu Gold Mine in the Eastern Highlands province of Papua New Guinea, as well as exploration and development of mineral deposits in the immediate vicinity of the mine, including Blue Lake, in Papua New Guinea. The Company holds the mining rights to Mining Lease 150 (ML 150). Within and surrounding ML 150 is an epithermal vein field consisting of multiple known and highly prospective vein systems: Kora, Irumafimpa, Karempe, Judd, Kora South, Judd South, Mati, Maniape and Arakompa. Mining is focused on the Kora vein system, consisting of two dominant veins and the Judd vein system consisting of four known veins with one vein being mined. There are multiple near-mine infrastructure targets, within the Kora-Kora South, Judd-Judd South and Karempe vein systems.


TSX:KNT - Post by User

Comment by LiveSimplyon Apr 15, 2022 12:49pm
263 Views
Post# 34606565

RE:KNT and Vectorvest

RE:KNT and Vectorvest

Also, anyone here follow analysts and companies on Seekin Alpha?

I'm not pushing it as you can subscribe for free for I think 30 days.
Analysts for nearly all companies post results, predictions, timelines, patent updates etc.
They also have extensive financial summaries.

i subscribe mostly to follow a basket of biotech genomics stocks such as
CRSP, NTLA, EDIT, BEAM, BMRN, CRBU ,etc where there is truly future medical breakthrough
on the horizon

Anyway, Taylor Dart has 4/13 article, K92 Mining: A Solid Start to the Year.
It's long and worth reading and you can view per free trial and then let trial run out.

<< Previous
Bullboard Posts
Next >>